PharmaForce International: Research Indicates Increased Presence of Medical Support Personnel in the Oncology/Hematology Space Across All Regions

READING, Pa., Oct. 11, 2018 /PRNewswire/ -- Research published by PharmaForce International (PFI) shows the average number of oncology medical roles within the four regions of study: The United States, Europe, Japan and Latin America grew over the prior year. This increase is part of a recent industry trend to expand promotional efforts and customer satisfaction in a challenging access environment. The Oncology Benchmarking reports examine a cross-section of various companies within each region (US, EU, Japan, LAM).

The US, profiling 33 companies, shows the most prevalent growth in medical support personnel at a 17% increase. The reports among European Countries – France, Germany, Italy, Spain and the U.K. each profile 14 companies. Altogether, Europe had a 13% increase in medical support personnel since 2017.

Each Latin American Country – Argentina, Brazil, Colombia and Mexico profiles between 11 and 12 companies. Overall, Latin America shows approximately a 7% increase in the presence of medical personnel in support of oncology/hematology. Japan, at a 6% increase, shows the lowest amount of growth in the presence of medical support personnel, which profiles 18 companies within the report.

Joyce Wedemeyer, Director of Marketing and Sales at PharmaForce International, says many companies are realizing the necessity of deploying field medical personnel to share scientific data and certify effective use of products. "It increases face time and ensures that product features/benefits are being communicated in a peer-to-peer format," says Wedemeyer.

Additional industry trends across regions captured in these reports include insight specific to:

• Expanded roles for Key Account Managers
• CAR-T therapy product launches
• Newly deployed field-based Marketing Managers
• Diagnostic Genetic Testing teams leveraged by pharmaceutical companies
• Emerging biosimilar competitors
• Newly deployed Thought Leader Teams to engage Key Opinion Leaders
• Commitment toward Health Economics Outcomes Research (HEOR) field-based personnel

For more information on the report mentioned above, please contact Joyce Wedemeyer at [email protected] or by phone at 610-370-2906.

PharmaForce International (PFI) is a competitive intelligence firm with over two decades of experience in the pharmaceutical and biotech industries. PFI has become the market leader in commercial operations benchmarking and competitive intelligence. The globally focused company employs market place experts uniquely qualified to perform research required by clients in most major pharmaceutical markets around the world.

SOURCE PharmaForce International

Related Links

https://www.pharmaforce.biz